About
Optimeos Life Sciences develops advanced nanoparticle and microparticle drug delivery platforms to improve the targeting, dosing, and efficacy of biologics, peptides, RNA, and gene therapies for rare diseases, immunology, and metabolic disorders.
Explore Optimeos Life Sciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.